Frontiers in Oncology · 2022 · 18 citations · 29 references
MedicineOncologyRadiologyBiomedical ImagingDiagnostic ImagingDiagnostic RadiologyHepatobiliary CancerHepatobiliary ImagingHepatocellular CarcinomaLiver CancerLiver ImagingTumor CharacterizationEarly Recurrence PredictionExternal Validation CohortsHepatocellular Carcinoma ImagingKi-67 ImagingKi-67 ImmunostainingTumor Aggressiveness AssessmentTumor Cell ProliferationTumor Proliferation Assessment
Objective: As an important biomarker to reflect tumor cell proliferation and tumor aggressiveness, Ki-67 is closely related to the high early recurrence rate and poor prognosis, and pretreatment evaluation of Ki-67 expression possibly provides a more accurate prognosis assessment and more better treatment plan. We aimed to develop a nomogram based on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) combined with T1 mapping to predict Ki-67 expression in hepatocellular carcinoma (HCC). Methods: This two-center study retrospectively enrolled 148 consecutive patients who underwent preoperative Gd-EOB-DTPA-enhanced MRI T1 mapping and surgically confirmed HCC from July 2019 to December 2020. The correlation between quantitative parameters from T1 mapping, ADC, and Ki-67 was explored. Three cohorts were constructed: a training cohort (n = 73) and an internal validation cohort (n = 31) from Shunde Hospital of Southern Medical University, and an external validation cohort (n = 44) from the Sixth Affiliated Hospital, South China University of Technology. The clinical variables and MRI qualitative and quantitative parameters associational with Ki-67 expression were analyzed by univariate and multivariate logistic regression analyses. A nomogram was developed based on these associated with Ki-67 expression in the training cohort and validated in the internal and external validation cohorts. Results: < 0.001). Predictors of Ki-67 expression included in the nomogram were peritumoral enhancement, peritumoral hypointensity, T1rt-20min, and tumor margin, while arterial phase hyperenhancement (APHE) was not a significant predictor even included in the regression model. The nomograms achieved good concordance indices in predicting Ki-67 expression in the training and two validation cohorts (0.919, 0.925, 0.850), respectively. Conclusions: T1rt-Pre and T1rt-20min had a strong positive correlation with the Ki-67 expression in HCC, and Gd-EOB-DTPA enhanced MRI combined with T1 mapping-based nomogram effectively predicts high Ki-67 expression in HCC.
29
Kyung‐Ah Kim, Myeong‐Jin Kim, Hyae Min Jeon et al. · Journal of Magnetic Resonance Imaging · 2011 · 182 citations · Full text
Seo‐Youn Choi, Seong Hyun Kim, Cheol Keun Park et al. · Radiology · 2017 · 144 citations